• Log in with Facebook Log in with Twitter Log In with Google      Sign In    
  • Create Account
  LongeCity
              Advocacy & Research for Unlimited Lifespans

Photo
- - - - -

Treatment potential of receptor-density increases induced by long-term receptor-antagonist treatment


  • Please log in to reply
4 replies to this topic

#1 rg8032

  • Guest
  • 25 posts
  • 14
  • Location:US

Posted 15 May 2012 - 02:59 AM


Has anyone considered the possible application of this methodology? Consider the following as a hypothetical example (some assumptions made).
  • Subject presents with anhedonia.
  • The underlying mechanism of the anhedonia is correctly diagnosed as a dysfunction of the dopamine system in areas of the brain.
  • A dopamine antagonist that inhibits these specific receptors is given to the patients at over a period of time.
  • Seeking homeostasis, the brain increases dopamine-receptor density.
  • The antagonist is later withdrawn leaving the subject with a surplus of dopamine receptors.
Could this effectively treat the subject's anhedonia? Could this produce a potentially positive withdrawal experience? Is there any research into this idea? Can you recommend any good literature on the effects of varying receptor density?

#2 medievil

  • Guest Guest
  • 3,758 posts
  • 20
  • Location:Belguim

Posted 19 May 2012 - 12:35 AM

This wont work as reward is not as simple as "moar dopamine" IMO reward is caused by either glutamate or the mu receptors with dopamine having a permissive role.

sponsored ad

  • Advert
Advertisements help to support the work of this non-profit organisation. To go ad-free join as a Member.

#3 nupi

  • Guest
  • 1,532 posts
  • 108
  • Location:Switzerland

Posted 20 May 2012 - 10:22 AM

Besides the points raised by medievil, wouldn't this make the patient go through an even worse anhedonia while he is using dopamine antagonists?

#4 jadamgo

  • Guest
  • 701 posts
  • 157
  • Location:USA

Posted 25 May 2012 - 03:12 AM

It's very hard to pick which dopamine receptors you want to sensitize and which you want to remain suppressed.

Long term use of dopamine antagonists causes tardive dyskinesia, which results from hypersensitization of dopamine receptors in the movement circuitry of the brain. The result? Unwanted, uncontrollable movements of muscles. Usually the facial muscles are involved, which can be very socially awkward, which introduces a new stressor into the environment. This does not aid recovery from mood or psychotic disorders.

Does it do the same thing to positive emotion? Evidently not. Depression is a well-known side effect of chronic antipsychotic treatment, so apparently the hedonic system does not fully sensitize when treated with dopamine antagonists. All the antipsychotics that help depression do things other than antagonize dopamine -- all atypicals are 5HT2A antagonists, aripiprazole is a D2 partial agonist, amisulpride is an irreversible 5HT7 antagonist, clozapine does all kinds of things, some of which we don't even know about yet...

On the contrary, reinforcement-related dopamine neurons do in fact sensitize when exposed to agonists like methamphetamine and cocaine. Obviously, drug addicts aren't the happiest people -- they're commonly depressed as well. This is because behavioral reinforcement conditioning and positive hedonic tone are not the same processes in the brain. Reinforcement mostly happens in secondary motor cortices and basal ganglia, whereas mood is a more complex phenomenon including processes across the cortex and also limbic and midbrain areas.

The result? People on antipsychotics stop caring about things, and people taking enough pro-dopaminergic drugs to affect emotion develop stereotyped behaviors (punding, tweaking...) and poorly controlled impulses to use the dopaminergic drug.

Really, I'm not criticizing the basic idea of inducing sensitization to a "good" receptor, I just don't think that antagonist treatment is the best way to do it. Complete tolerance to a drug, equal in all receptor subtypes and having equal effects in all relevant systems, is just plain rare. Way more common is the above-mentioned mess where some receptors are sensitized, some haven't changed so they're still under the influence of the drug, and sometimes you'll even encounter receptors that down-regulate in response to antagonists! (I believe 5HT2A does this. But only for inverse agonists, not ordinary antagonists.)

I might know of an exception, though. Ibogaine puts people in a miserable mood for the entire multi-day duration of the trip, but sometimes an extended period of mood elevation follows. It can last weeks to months. Here's the big question: Is mood elevation a direct chemical effect of ibogaine (de)sensitizing receptors? Or is it explained better by psychological phenomena of cognitive and behavioral changes? As an analogy, people commonly take LSD or mushrooms and then they don't feel any different afterwards. But sometimes people take hallucinogens and they see parts of themselves and their lives from new perspectives, and they retain those new perspectives long after the drug has left their systems and the tolerance has ended. Maybe ibogaine does that. Or maybe not.

sponsored ad

  • Advert
Advertisements help to support the work of this non-profit organisation. To go ad-free join as a Member.

#5 gizmobrain

  • Guest
  • 548 posts
  • 105
  • Location:USA

Posted 22 September 2012 - 05:01 AM

I've thought about using amisulpride for attempting this. Not long term, but using it on weekends to upregulate any downregulation that may have occurred due to stimulant use for the work week.

Unfortunately, I'm not sure the best source for a guy in the USA since it isn't approved here.




1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users